Link Pharma Chem reported audited FY26 net profit of ₹7.69 lakhs, a significant improvement from FY25 loss of ₹102.73 lakhs.
Board approved reappointments of Chairman Satish Thakur and MD Rishikesh Thakur for 3-year terms, subject to shareholder approval.
Reappointed Vijay Bhatt & Co. as Secretarial Auditor, Dipak Rajpara & Co. as Internal Auditor, and Y.S. Thakar & Co. as Cost Auditor.
FY26 revenue stood at ₹2,743.15 lakhs with operating cash flow of ₹214.65 lakhs and investments in property plant & equipment of ₹209.99 lakhs.